These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6410976)

  • 21. Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases.
    Sandyk R; Hurwitz MD
    S Afr Med J; 1983 Nov; 64(22):875-6. PubMed ID: 6415823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.
    Rosengarten H; Bartoszyk GD; Quartermain D; Lin Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):273-9. PubMed ID: 16229932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia in a neuroleptic-naive patient with bipolar-I disorder: persistent exacerbation after lithium intoxication.
    Meyer-Lindenberg A; Krausnick B
    Mov Disord; 1997 Nov; 12(6):1108-9. PubMed ID: 9399254
    [No Abstract]   [Full Text] [Related]  

  • 26. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol: a quarter century of experience.
    Settle EC; Ayd FJ
    J Clin Psychiatry; 1983 Dec; 44(12):440-8. PubMed ID: 6418723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mania associated with the use of baclofen.
    Wolf ME; Almy G; Toll M; Mosnaim AD
    Biol Psychiatry; 1982 Jun; 17(6):757-9. PubMed ID: 6809063
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination of reserpine with lithium in the treatment of manic-depression resistant to lithium].
    Gayral LF; Escande M; Goldberger E
    Ann Med Psychol (Paris); 1979; 137(5):506-16. PubMed ID: 507598
    [No Abstract]   [Full Text] [Related]  

  • 31. Lithium - induced tardive dystonia.
    Chakrabarti S; Chand PK
    Neurol India; 2002 Dec; 50(4):473-5. PubMed ID: 12577099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
    Goodnick PJ; Meltzer HY
    J Clin Psychopharmacol; 1983 Aug; 3(4):239-43. PubMed ID: 6411776
    [No Abstract]   [Full Text] [Related]  

  • 33. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative evaluation of the effect of lithium carbonate, haloperidol and preparation IB-503 in the treatment of manic states].
    Nuller IuL; Rabinovich MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(2):277-83. PubMed ID: 5572074
    [No Abstract]   [Full Text] [Related]  

  • 35. Striatal membrane 3H-dopamine binding in an animal model of tardive dyskinesia.
    Klawans HL; Hitri A
    Psychopharmacol Bull; 1978 Oct; 14(4):72-6. PubMed ID: 704768
    [No Abstract]   [Full Text] [Related]  

  • 36. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.
    Holcomb HH; Sternberg DE; Heninger GR
    Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.
    Delfs JM; Ellison GD; Mercugliano M; Chesselet MF
    Exp Neurol; 1995 Jun; 133(2):175-88. PubMed ID: 7544289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of drug holidays in an animal model of tardive dyskinesia.
    Bannet J; Belmaker RH; Ebstein RP
    Psychopharmacology (Berl); 1980; 69(2):223-4. PubMed ID: 6779315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.